pentobarbital will reduce the level or impact of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.Contraindicated (1)pentobarbital will minimize the extent or result of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is liable for the development and elimination of cariprazine's … Read More